Pivotal, which specializes in developing and managing clinical trials for the pharmaceutical and biotechnological industry, receives this recognition for the strength of its management model, the quality of its processes, and its commitment to scientific innovation.
A Life Sciences Founder & Investor Event
Join founders, investors and leaders from across the life sciences community for an evening of conversation, insight and networking.
Delivering reduced hands-on time, more consistent results and higher sample throughout
Oxford, UK, 24th September.
OGT, a leading global provider of genomic research and diagnostic solutions today unveiled next-generation sequencing (NGS) automation capabilities across its SureSeq™ NGS portfolio, compatible with the Hamiton NGS STAR Line. The latest advancement in OGT’s ongoing SureSeq investment, these automated workflows help laboratories optimise resources and deliver turnaround time targets.
Amsbio announce a new partnership with Atelerix to introduce its patented hydrogel technology for the room-temperature storage and transportation of living cells, tissues, organoids and viruses.
New service brings senior regulatory expertise into the early development window, when strategic decisions can have the greatest impact.
DLRC, an award-winning global regulatory and market access consultancy that supports the development and licensing of pharmaceutical, biotech, advanced therapy, and medtech products worldwide, launches Regulatory Spark, a new fixed-fee, fast-turnaround service created for early-stage innovators.
Barry Callebaut, the world’s leading manufacturer of high-quality chocolate and cocoa solutions, has moved into Colworth Science Park’s food tech incubator Gastronomica.
Gastronomica is a home for ambitious food-tech businesses advancing the future of food, enabling innovators and industry leaders to scale ideas, tackle global food shortages, and drive sustainable solutions.
📣 Join HBA Cambridge and Deloitte for 𝐏𝐢𝐨𝐧𝐞𝐞𝐫𝐢𝐧𝐠 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐚 𝐇𝐞𝐚𝐥𝐭𝐡𝐢𝐞𝐫 𝐅𝐮𝐭𝐮𝐫𝐞 on 30 September.
This event will explore how a prevention-first approach can improve health outcomes, reduce health inequalities, strengthen healthcare sustainability, and keep the patient voice at the heart of innovation.
Hear from leaders across healthcare, life sciences, public health, and patient advocacy, with the discussion moderated by Elizabeth Hampson, UK Life Sciences and Health Innovation Partner at Deloitte.
Beacon for rare diseases, a Cambridge-based charity, has just launched Rare Insights – a ground-breaking study exploring the value and impact of rare disease patient groups, alongside the challenges they face.
Patient groups are often the first port-of-call for newly diagnosed patients with a rare disease. By providing much-needed support to individuals with rare diseases and their families, they become a lifeline, frequently advocating for research and helping to shape policies that put patients at their heart.
How do you drug the undruggable?
This is the question Jon Heal, EVP In Silico at RxCelerate, will tackle in our upcoming webinar, exploring how hidden binding sites can be uncovered in challenging drug targets.